Wellington Mendes

5PUBLICATIONS
15CO-AUTHORS
Haematological tumoursGene and molecular therapyTraditional, complementary and integrative medicine not elsewhere classifiedModels of care and place of birth
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Sep 16, 2022
Long-term follow-up of VIALE-C in patients with untreated AML ineligible for intensive chemotherapy.

Andrew H Wei, Panayiotis Panayiotidis, Pau Montesinos

|May 14, 2022
Timing of response with venetoclax combination treatment in patients with newly diagnosed acute myeloid leukemia.

Brian A Jonas, Andrew H Wei, Christian Recher

|Apr 21, 2022
Venetoclax combinations delay the time to deterioration of HRQoL in unfit patients with acute myeloid leukemia.

Keith W Pratz, Panayiotis Panayiotidis, Christian Recher

|Oct 27, 2021
Author Correction: 6-month follow-up of VIALE-C demonstrates improved and durable efficacy in patients with untreated AML ineligible for intensive chemotherapy.

Andrew H Wei, Panayiotis Panayiotidis, Pau Montesinos

|Oct 02, 2021
6-month follow-up of VIALE-C demonstrates improved and durable efficacy in patients with untreated AML ineligible for intensive chemotherapy (141/150).

Andrew H Wei, Panayiotis Panayiotidis, Pau Montesinos

Pageof 1

Frequent Collaborators

5 joint publications

Pau Montesinos

4 joint publications

Andrew H Wei

3 joint publications

Achilles Anagnostopoulos

3 joint publications

Courtney D DiNardo